乳腺癌与催乳素：一生的关联。
BREAST CANCER AND PROLACTIN: A LIFETIME RELATIONSHIP.
作者信息
Lempidaki P, Zervoudis S, Michou V, Eskitzis P, Iatrakis G, Mastorakos G
机构信息
Department of Midwifery, University of West Attica, Athens, Greece.
Department of Mastology, Rea Hospital, Athens, Greece.
出版信息
Acta Endocrinol (Buchar). 2024 Jul-Sep;20(3):349-355. doi: 10.4183/aeb.2024.349. Epub 2025 May 23.
Abstract
Prolactin is a multifunctional hormone produced by the pituitary gland, essential for more than just the growth of mammary tissue. It plays a crucial role in lobuloalveolar development and lactation. Understanding multifunctional hormone, prolactin, and its role in breast tissue is a promising avenue in our fight against breast cancer. This paper aims to shed light on the physiological mechanisms of prolactin in breast cancer, its prognostic value, and potential therapeutic approaches, offering a significant step forward in our battle against this disease.
摘要
催乳素是一种由垂体分泌的多功能激素，其作用远不止于乳腺组织的生长。它在小叶腺泡发育和泌乳过程中起着关键作用。了解多功能激素催乳素及其在乳腺组织中的作用，是我们对抗乳腺癌的一条充满希望的途径。本文旨在阐明催乳素在乳腺癌中的生理机制、其预后价值及潜在的治疗方法，为我们对抗这种疾病迈出重要的一步。
相似文献
1
BREAST CANCER AND PROLACTIN: A LIFETIME RELATIONSHIP.乳腺癌与催乳素：一生的关联。
Acta Endocrinol (Buchar). 2024 Jul-Sep;20(3):349-355. doi: 10.4183/aeb.2024.349. Epub 2025 May 23.
2
Interventions for fertility preservation in women with cancer undergoing chemotherapy.对接受化疗的癌症女性进行生育力保存的干预措施。
Cochrane Database Syst Rev. 2025 Jun 19;6:CD012891. doi: 10.1002/14651858.CD012891.pub2.
3
St Andrews Referral Delay in Skin Cancer (StARDISC): a study of keratinocyte skin cancer time to treatment, growth, invasiveness, British Association of Dermatologists risk factors and excision adequacy.圣安德鲁斯皮肤癌转诊延迟研究（StARDISC）：一项关于角质形成细胞皮肤癌治疗时间、生长、侵袭性、英国皮肤科医师协会危险因素及切除充分性的研究。
Br J Dermatol. 2025 Jun 20;193(1):157-166. doi: 10.1093/bjd/ljaf097.
4
Adapting Safety Plans for Autistic Adults with Involvement from the Autism Community.在自闭症群体的参与下为成年自闭症患者调整安全计划。
Autism Adulthood. 2025 May 28;7(3):293-302. doi: 10.1089/aut.2023.0124. eCollection 2025 Jun.
5
Prognostic factors for return to work in breast cancer survivors.乳腺癌幸存者恢复工作的预后因素。
Cochrane Database Syst Rev. 2025 May 7;5(5):CD015124. doi: 10.1002/14651858.CD015124.pub2.
6
Network and systems biology approaches help investigate gene regulatory interactions between Salmonella disease and host in chickens: Model-based in silico evidence combined with gene expression assays.网络和系统生物学方法有助于研究沙门氏菌病与鸡宿主之间的基因调控相互作用：基于模型的计算机模拟证据与基因表达分析相结合。
Vet Med Sci. 2024 Nov;10(6):e70006. doi: 10.1002/vms3.70006.
7
Regional analgesia techniques for postoperative pain after breast cancer surgery: a network meta-analysis.乳腺癌手术后疼痛的区域镇痛技术：一项网状Meta分析
Cochrane Database Syst Rev. 2025 Jun 4;6(6):CD014818. doi: 10.1002/14651858.CD014818.pub2.
8
Applications of Indocyanine Green in Breast Cancer for Sentinel Lymph Node Mapping: Protocol for a Scoping Review.吲哚菁绿在乳腺癌前哨淋巴结定位中的应用：一项范围综述方案
JMIRx Med. 2025 Jan 6;6:e66213. doi: 10.2196/66213.
9
Molecular feature-based classification of retroperitoneal liposarcoma: a prospective cohort study.基于分子特征的腹膜后脂肪肉瘤分类：一项前瞻性队列研究。
Elife. 2025 May 23;14:RP100887. doi: 10.7554/eLife.100887.
10
The multiple functions of CD5 in diseases related to immune disorders.CD5在免疫紊乱相关疾病中的多种功能。
Ann Med. 2025 Dec;57(1):2519682. doi: 10.1080/07853890.2025.2519682. Epub 2025 Jun 20.
本文引用的文献
1
Association of antipsychotic use with breast cancer: a systematic review and meta-analysis of observational studies with over 2 million individuals.抗精神病药物使用与乳腺癌的关联：一项纳入超过 200 万人的观察性研究的系统评价和荟萃分析。
Epidemiol Psychiatr Sci. 2022 Sep 5;31:e61. doi: 10.1017/S2045796022000476.
2
Prolactin: The Third Hormone in Breast Cancer.催乳素：乳腺癌的第三激素。
Front Endocrinol (Lausanne). 2022 Jun 16;13:910978. doi: 10.3389/fendo.2022.910978. eCollection 2022.
3
Risk of cancer in bipolar disorder and the potential role of lithium: International collaborative systematic review and meta-analyses.双相障碍患者的癌症风险和锂的潜在作用：国际协作系统回顾和荟萃分析。
Neurosci Biobehav Rev. 2021 Jul;126:529-541. doi: 10.1016/j.neubiorev.2021.03.034. Epub 2021 Apr 5.
4
Prolactin receptor expression as a novel prognostic biomarker for triple negative breast cancer patients.催乳素受体表达作为三阴性乳腺癌患者的新型预后生物标志物。
Ann Diagn Pathol. 2020 Jun;46:151507. doi: 10.1016/j.anndiagpath.2020.151507. Epub 2020 Mar 13.
5
Analysis and reporting of adverse events in randomised controlled trials: a review.随机对照试验中不良事件的分析和报告：综述。
BMJ Open. 2019 Mar 1;9(2):e024537. doi: 10.1136/bmjopen-2018-024537.
6
Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions.催乳素升高的抗精神病药通过激活癌前病变中的 JAK-STAT5 增加乳腺癌风险。
Breast Cancer Res. 2018 May 19;20(1):42. doi: 10.1186/s13058-018-0969-z.
7
A pilot study of cabergoline for the treatment of metastatic breast cancer.卡麦角林治疗转移性乳腺癌的初步研究。
Breast Cancer Res Treat. 2017 Oct;165(3):585-592. doi: 10.1007/s10549-017-4370-x. Epub 2017 Jul 3.
8
Breastfeeding Mode and Risk of Breast Cancer: A Dose-Response Meta-Analysis.母乳喂养方式与乳腺癌风险：一项剂量反应荟萃分析。
J Hum Lact. 2017 May;33(2):422-434. doi: 10.1177/0890334416683676. Epub 2017 Feb 14.
9
A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.催乳素在人类乳腺癌中的有利作用揭示了基于新途径的基因特征，这些特征表明肿瘤分化良好且患者预后良好。
Hum Pathol. 2016 Jul;53:142-52. doi: 10.1016/j.humpath.2016.02.010. Epub 2016 Mar 14.
10
Breastfeeding and breast cancer risk by receptor status--a systematic review and meta-analysis.按受体状态划分的母乳喂养与乳腺癌风险——一项系统评价和荟萃分析
Ann Oncol. 2015 Dec;26(12):2398-407. doi: 10.1093/annonc/mdv379. Epub 2015 Oct 26.
Zotero 插件